Integral Diagnostics logo

Integral Diagnostics(ASX) IDX

Market CapA$802.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)+65%
5 Year-50%
1 Year-19%
1 Month-7%
A$2.12
-1.40%
-0.03Today
Integral Diagnostics last closing stock price
MetricPriceDate
Last closeAUD 2.122026-10-12
Integral Diagnostics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.47%AUD 2.132026-10-05
1 month-7.02%AUD 2.282026-09-11
3 month+5.12%AUD 2.022026-07-14
Year to date-13.15%AUD 2.442025-12-31
1 year-18.6%AUD 2.602025-10-10
3 year-15.17%AUD 2.502023-10-13
5 year-49.99%AUD 4.242021-10-13
Since inception+64.7%AUD 1.312015-10-21

Integral Diagnostics Financials at a Glance

Market Cap

A$802.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$1.42B

Net Income (TTM)

A$26.61M

EPS (TTM)

A$0.06

P/E Ratio

36.50

Dividend

A$0.09

Beta (Volatility)

0.15 (Low)

Price

A$2.12

Volume

214,457

Open

A$2.12

Previous Close

A$2.12

Daily Range

A$2.12 - A$2.15

52-Week Range

A$1.91 - A$2.71

Estimated Earnings Date

Feb 16, 2027

IDX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Integral Diagnostics

Integral Diagnostics Limited operates within the healthcare sector, providing essential diagnostic imaging services across Australia and New Zealand. The company manages a network of 67 radiology clinics, delivering services to general practitioners, medical specialists, and allied health professionals.

Products and Services
  • Diagnostic imaging services including X-rays, MRIs, and CT scans
  • Specialized imaging for various medical conditions
  • Telehealth services for remote consultations
Growth Outlook
  • Revenue of AUD 395.14 million in the latest quarter, showing consistent growth
  • Strong demand for diagnostic services in the healthcare sector
  • Expansion plans for additional clinics to enhance service reach
Financial Highlights
  • Net income of AUD 12.98 million for the latest quarter
  • Operating cash flow of AUD 62.40 million, indicating strong liquidity
  • Dividend yield of 4.08%, reflecting commitment to shareholder returns
Integral Diagnostics Limited has established itself as a key player in the diagnostic imaging market, benefiting from a growing demand for healthcare services. The company's recent financial performance highlights its ability to generate substantial revenue and maintain a healthy cash flow, which is crucial for ongoing operations and expansion. With plans to increase its clinic network, Integral Diagnostics is well-positioned to capitalize on the rising need for diagnostic services in the region. The attractive dividend yield further enhances its appeal to potential investors, indicating a focus on returning value to shareholders while pursuing growth opportunities.
AI Generated • Sep 19, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

3,049

CEO

Ian Kadish, MBA

Website

www.integraldiagnostics.com.au

Headquarters

Melbourne, VIC 3002, AU

IDX Financials

Key Financial Metrics (TTM)

Gross Margin

21.40%

Operating Margin

8.68%

Net Income Margin

2.78%

Return on Equity

3.24%

Return on Capital

5.31%

Return on Assets

1.50%

Earnings Yield

2.74%

Dividend Yield

4.33%

Payout Ratio

1.18%

Stock Overview

Market Cap

A$802.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

373.12M

Volume

214.46K

Avg. Volume

1.01M

Financials (TTM)

Gross Profit

A$332.06M

Operating Income

A$160.44M

EBITDA

A$247.92M

Operating Cash Flow

A$169.01M

Capital Expenditure

-A$109.40M

Free Cash Flow

A$59.61M

Cash & ST Invst.

A$51.29M

Total Debt

A$597.10M

Integral Diagnostics Performance Analysis

Integral Diagnostics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 440,099,00022.7%
20242024-06-30AUD 469,697,0006.7%
20252025-06-30AUD 627,215,00033.5%
20262026-06-30AUD 788,619,00025.7%
Integral Diagnostics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-316.1%
Q42025-06-3048.0%
Q22025-12-315.1%
Q42026-06-300.4%
Integral Diagnostics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD 0.1156.2%
20242024-06-30AUD -0.26N/A
20252025-06-30AUD 0.01N/A
20262026-06-30AUD 0.06569.0%
Integral Diagnostics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-106.2%
Q42025-06-30950.0%
Q22025-12-3175.0%
Q42026-06-3044.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$395.14M

+65.7%

Gross Profit

A$83.96M

+58.8%

Gross Margin

21.25%

N/A

Market Cap

A$802.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$263.10K

N/A

Employees

3,049

N/A

Net Income

A$12.98M

+114.2%

EBITDA

A$72.35M

+65.3%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$51.29M

+20.8%

Total Debt

A$597.10M

+67.9%

Accounts Receivable

A$35.66M

+45.6%

Inventory

A$3.42M

+107.1%

Long Term Debt

A$575.64M

+68.5%

Short Term Debt

A$21.46M

+32.7%

Return on Assets

1.50%

N/A

Return on Invested Capital

5.22%

N/A

Free Cash Flow

A$37.62M

-3.1%

Operating Cash Flow

A$62.40M

+22.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ACL.AXAustralian Clinical Labs Limited
A$2.91-1.02%
HLS.AXHealius Limited
A$0.39+0.00%
SHL.AXSonic Healthcare Limited
A$18.59-0.32%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$6.75+0.22%
BITOProShares Trust - ProShares Bitcoin ETF
$11.00+0.00%
SPCXSpace Exploration Technologies
$163.92+0.83%
NOKNokia
$9.96-3.86%

Questions About IDX

What is the current price of Integral Diagnostics?

Integral Diagnostics is trading at A$2.12 per share.

What is the 52-week range for Integral Diagnostics?

Over the past 52 weeks, Integral Diagnostics has traded between A$1.91 and A$2.71.

How much debt does Integral Diagnostics have?

As of the most recent reporting period, Integral Diagnostics reported total debt of A$597.10M.

How much cash does Integral Diagnostics have on hand?

Integral Diagnostics reported A$51.29M in cash and cash equivalents in its most recent financial results.

What is Integral Diagnostics’s dividend yield?

Integral Diagnostics currently has a dividend yield of 4.33%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services